Polaris Wealth Advisory Group, LLC Gilead Sciences, Inc. Transaction History

Polaris Wealth Advisory Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$64.88 - $73.64 $26.3 Million - $29.9 Million	-405,666 Closed	0 $0
Q3 2021 Oct 18, 2021	SELL	$67.69 - $73.03 $7.41 Million - $7.99 Million	-109,409 Reduced 21.24%	405,666 $27.6 Million
Q2 2021 Jul 23, 2021	BUY	$63.47 - $69.35 $3.81 Million - $4.17 Million	60,083 Added 13.21%	515,075 $35.6 Million
Q1 2021 Apr 19, 2021	BUY	$60.0 - $68.46 $27.3 Million - $31.1 Million	454,992 New	454,992 $29.6 Million
Q1 2019 Apr 09, 2019	SELL	$62.53 - $70.05 $609,667 - $682,987	-9,750 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$60.54 - $79.0 $297,917 - $388,759	4,921 Added 101.91%	9,750 $610,000
Q3 2018 Oct 19, 2018	BUY	$71.28 - $78.92 $344,211 - $381,104	4,829 New	4,829 $373,000
Q2 2018 Jul 09, 2018	SELL	$64.88 - $75.68 $3,244 - $3,784	-50 Closed	0 $0
Q1 2018 Apr 09, 2018	BUY	$72.84 - $88.8 $3,642 - $4,440	50 New	50 $4,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Polaris Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Polaris Wealth Advisory Group, LLC with notifications on news.